TRiCares raises $50m to trial tricuspid heart valve replacement system
European device company TRiCares has raised $50m in a Series D financing round to develop its transfemoral tricuspid heart valve…
European device company TRiCares has raised $50m in a Series D financing round to develop its transfemoral tricuspid heart valve…
NewAmsterdam Pharma has completed the enrolment of 407 patients in the pivotal Phase III TANDEM clinical trial evaluating obicetrapib in…
The US National Institutes of Health (NIH) has reported that exploratory analysis data from a clinical trial of an antiretroviral…
Massachusetts, US-based cardiology biotech Cardurion Pharmaceuticals has raised $260m in Series B financing to advance its drug pipeline. The proceeds…
Dutch biotechnology company NewAmsterdam Pharma has finished enrolling subjects in a Phase III trial of a combination therapy for heterozygous…
Saudi Arabia's King Faisal Specialist Hospital & Research Centre (KFSH&RC) has reported a 98% survival rate for 400 robotic cardiac…
Novo Nordisk has said it will take a DKr5.7bn ($816m) hit after its acquired drug ocedurenone flopped in the Phase…
The Northern Hemisphere is currently in the grip of a heatwave. The heatwave has now stretched across North America, Europe,…
Tectonic Therapeutic has completed a reverse merger with Avrobio and will begin trading on the Nasdaq global market as Tectonic…
The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to Xeltis, green-lighting a pivotal study…